Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

Biosimilars of certolizumab pegol

$
0
0
Certolizumab pegol is a monoclonal antibody directed against tumour necrosis factoralfa TNF. More precisely it is a PEGylated Fab fragment of a humanized TNF inhibitor monoclonal antibody. It is indicated for the treatment of Crohns disease rheumatoid arth...

Viewing all articles
Browse latest Browse all 2985

Trending Articles